Nxstage Medical, Inc. (Nasdaq: NXTM) is 27% lower this morning following disappointing Q4 results and guidance.

Nxstage Medical reported ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE